ArticleCell cycle (Georgetown, Tex.)2018

Regorafenib regresses an imatinib-resistant recurrent gastrointestinal stromal tumor (GIST) with a mutation in exons 11 and 17 of c-kit in a patient-derived orthotopic xenograft (PDOX) nude mouse model.

Kentaro Miyake et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.